Get to know our clinical trials

Fosfomycin as an oral alternative therapy in the treatment of acute bacterial prostatitis caused by multidrug-resistant Escherichia coli

THE AIM OF THE STUDY IS TO EVALUATE THE EFFICACY OF SEQUENTIAL TREATMENT WITH ORAL FOSFOMYCIN IN PATIENTS DIAGNOSED WITH PROSTATITIS AFTER 2 TO 5 DAYS OF THERAPY WITH AN ANTIBIOTIC SUITABLE FOR THE MICROORGANISM ISOLATED PARENTERALLY, ALSO STUDYING THE PHARMACOKINETIC PARAMETERS OF ORAL FOSFOMYCIN, IN ORDER TO FIND AN EFFECTIVE AND SAFE TREATMENT REGIMEN THAT IMPROVES THE PATIENT'S QUALITY OF LIFE, REDUCING THE NUMBER OF DAYS OF HOSPITALIZATION AND AVOIDING SIDE EFFECTS

Dr. Sara Antón Cruz [SP] Curriculum
Specialist Psychiatry and Clinical Psychology Department
Madrid headquarters
Status
In recruitment
headquarters
Pamplona
Early phase

Technical Summary

  • FOSFOMYCIN AS AN ORAL ALTERNATIVE THERAPY IN THE TREATMENT OF ACUTE BACTERIAL PROSTATITIS CAUSED BY MULTIDRUG-RESISTANT ESCHERICHIA COLI
  • Code EudraCT: 2019-003792-19
  • Protocol number: FOS-PROST-001
  • Promoter: Fundación Miguel Servet

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

More information about this clinical trial

Information offered by the Spanish Registry of Clinical Studies

  • Summary
  • Information
  • Calendar
  • Headquarters
  • Drugs
Read more about this clinical trial
Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial

I want to make an appointment
Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.

I WANT TO REQUEST A SECOND OPINION